Literature DB >> 28164244

Candida krusei and Candida glabrata reduce the filamentation of Candida albicans by downregulating expression of HWP1 gene.

Patrícia Pimentel de Barros1, Fernanda Freire1, Rodnei Dennis Rossoni2, Juliana Campos Junqueira1, Antonio Olavo Cardoso Jorge1.   

Abstract

Pathogenicity of Candida albicans is associated with its capacity switch from yeast-like to hyphal growth. The hyphal form is capable to penetrate the epithelial surfaces and to damage the host tissues. Therefore, many investigations have focused on mechanisms that control the morphological transitions of C. albicans. Recently, certain studies have showed that non-albicans Candida species can reduce the capacity of C. albicans to form biofilms and to develop candidiasis in animal models. Then, the objective of this study was to evaluate the effects of Candida krusei and Candida glabrata on the morphogenesis of C. albicans. Firstly, the capacity of reference and clinical strains of C. albicans in forming hyphae was tested in vitro. After that, the expression of HWP1 (hyphal wall protein 1) gene was determined by quantitative real-time PCR (polymerase chain reaction) assay. For both reference and clinical strains, a significant inhibition of the hyphae formation was observed when C. albicans was incubated in the presence of C. krusei or C. glabrata compared to the control group composed only by C. albicans. In addition, the culture mixed of C. albicans-C. krusei or C. albicans-C. glabrata reduced significantly the expression of HWP1 gene of C. albicans in relation to single cultures of this specie. In both filamentation and gene expression assays, C. krusei showed the higher inhibitory activity on the morphogenesis of C. albicans compared to C. glabrata. C. krusei and C. glabrata are capable to reduce the filamentation of C. albicans and consequently decrease the expression of the HWP1 gene.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28164244     DOI: 10.1007/s12223-017-0500-4

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  38 in total

Review 1.  Regulatory networks controlling Candida albicans morphogenesis.

Authors:  A J Brown; N A Gow
Journal:  Trends Microbiol       Date:  1999-08       Impact factor: 17.079

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Candida albicans biofilms: more than filamentation.

Authors:  José L López-Ribot
Journal:  Curr Biol       Date:  2005-06-21       Impact factor: 10.834

Review 4.  Global trends in the distribution of Candida species causing candidemia.

Authors:  J Guinea
Journal:  Clin Microbiol Infect       Date:  2014-03-06       Impact factor: 8.067

5.  Candida albicans HWP1 gene expression and host antibody responses in colonization and disease.

Authors:  Julian R Naglik; Florentia Fostira; Jasmeet Ruprai; Janet F Staab; Stephen J Challacombe; Paula Sundstrom
Journal:  J Med Microbiol       Date:  2006-10       Impact factor: 2.472

6.  Real-time PCR expression profiling of genes encoding potential virulence factors in Candida albicans biofilms: identification of model-dependent and -independent gene expression.

Authors:  Heleen Nailis; Sona Kucharíková; Markéta Ricicová; Patrick Van Dijck; Dieter Deforce; Hans Nelis; Tom Coenye
Journal:  BMC Microbiol       Date:  2010-04-16       Impact factor: 3.605

7.  Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities.

Authors:  Hilmar Wisplinghoff; Jenny Ebbers; Lea Geurtz; Danuta Stefanik; Yvette Major; Michael B Edmond; Richard P Wenzel; Harald Seifert
Journal:  Int J Antimicrob Agents       Date:  2013-10-12       Impact factor: 5.283

8.  Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells.

Authors:  Quynh T Phan; Carter L Myers; Yue Fu; Donald C Sheppard; Michael R Yeaman; William H Welch; Ashraf S Ibrahim; John E Edwards; Scott G Filler
Journal:  PLoS Biol       Date:  2007-03       Impact factor: 8.029

9.  Clinical and therapeutic aspects of candidemia: a five year single centre study.

Authors:  Matteo Bassetti; Maria Merelli; Filippo Ansaldi; Daniela de Florentiis; Assunta Sartor; Claudio Scarparo; Astrid Callegari; Elda Righi
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

10.  The role of Candida albicans SPT20 in filamentation, biofilm formation and pathogenesis.

Authors:  Xiaojiang Tan; Beth Burgwyn Fuchs; Yan Wang; Weiping Chen; Grace J Yuen; Rosalyn B Chen; Elamparithi Jayamani; Cleo Anastassopoulou; Read Pukkila-Worley; Jeffrey J Coleman; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more
  2 in total

1.  Clinical strains of Lactobacillus reduce the filamentation of Candida albicans and protect Galleria mellonella against experimental candidiasis.

Authors:  Rodnei Dennis Rossoni; Marisol Dos Santos Velloso; Lívia Mara Alves Figueiredo; Carolina Pistille Martins; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Folia Microbiol (Praha)       Date:  2017-11-23       Impact factor: 2.099

Review 2.  Current Aspects in the Biology, Pathogeny, and Treatment of Candida krusei, a Neglected Fungal Pathogen.

Authors:  Manuela Gómez-Gaviria; Héctor M Mora-Montes
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.